review Open AccessTop 1% cited

Diverse Applications of Nanomedicine

ACS Nano · 2017 · Vol. 11(3) · pp. 2313–2381

Beatriz Pelaz✉Christoph Alexiou(University of Utah)Ramón A. Álvarez‐Puebla(Institució Catalana de Recerca i Estudis Avançats)Frauke Alves(Max Planck Institute of Experimental Medicine)Anne M. Andrews(California NanoSystems Institute)Sumaira AshrafLajos Balogh(Chinese Academy of Sciences)Laura Ballerini(Scuola Internazionale Superiore di Studi Avanzati)Alessandra Bestetti(The University of Melbourne)Cornelia Brendel(Philipps University of Marburg)Susanna Bosi(University of Trieste)Mónica Carril(Ikerbasque)Warren C. W. Chan(University of Toronto)Chunying Chen(National Center for Nanoscience and Technology)Xiaodong Chen(National Institutes of Health)Xiaoyuan Chen(National Institutes of Health)Zhen Cheng(Stanford University)Daxiang Cui(Shanghai Jiao Tong University)Jianzhong Du(Tongji University)Christian Dullin(Seoul National University)Alberto Escudero(Instituto de Ciencia de Materiales de Sevilla)Neus Feliu(Karolinska Institutet)Mingyuan Gao(Chinese Academy of Sciences)Michael George(Nanion (Germany))Yury Gogotsi(Drexel University)Arnold Grünweller(Philipps University of Marburg)Zhongwei Gu(Sichuan University)Naomi J. Halas(Rice University)Norbert Hampp(Philipps University of Marburg)Roland K. Hartmann(Philipps University of Marburg)Mark C. Hersam(Northwestern University)Patrick Hunziker(University Hospital of Basel)Jian Ji(Zhejiang University)Xingyu Jiang(National Center for Nanoscience and Technology)Philipp Jungebluth(Heidelberg University)Pranav Kadhiresan(University of Toronto)Kazunori Kataoka(Bunkyo University)Ali KhademhosseiniJindřich Kopeček(University of Utah)Nicholas A. Kotov(University of Utah)Harald F. Krug(University of Michigan)Dong Soo Lee(Seoul National University)Claus‐Michael Lehr(Helmholtz Institute for Pharmaceutical Research Saarland)Kam W. Leong(California NanoSystems Institute)Xing‐Jie Liang(Chinese Academy of Sciences)Mei Ling Lim(Karolinska Institutet)Luis M. Liz‐Marzán(Ikerbasque)Xiaowei Ma(Scuola Internazionale Superiore di Studi Avanzati)Paolo Macchiarini(The University of Melbourne)Huan Meng(Ikerbasque)Helmuth Möhwald(Emory University)Paul Mulvaney(The University of Melbourne)André E. Nel(Ikerbasque)Shuming Nie(University of Trieste)Peter Nordlander(Rice University)Teruo Okano(Tokyo Women's Medical University)J.P.R. de Oliveira(University of Toronto)Tai Hyun Park(Nanyang Technological University)Reginald M. Penner(University of California, Irvine)Maurizio Prato(Ikerbasque)Víctor Puntes(Institució Catalana de Recerca i Estudis Avançats)Vincent M. Rotello(University of Massachusetts Amherst)Amila Samarakoon(University of Toronto)Raymond E. Schaak(Pennsylvania State University)Youqing Shen(Tongji University)Sebastian Sjöqvist(Karolinska Institutet)André G. Skirtach(Karolinska Institutet)Mahmoud G. Soliman(Karolinska Institutet)Molly M. Stevens(Imperial College London)Hsing‐Wen Sung(National Tsing Hua University)Ben Zhong Tang(National Research Center for Rehabilitation Technical Aids)Rainer Tietze(University of Utah)Buddhisha Udugama(University of Toronto)J. Scott VanEpps(University of Michigan)Tanja Weil(Universität Ulm)Paul S. Weiss(Northwestern University)Itamar Willner(Northwestern University)Yuzhou Wu(Max Planck Institute for Polymer Research)Lily Yang(University of Toronto)Yue Zhao(Pennsylvania State University)Qian Zhang(Peking University)Qiang Zhang(Peking University)Xian‐En Zhang(Chinese Academy of Sciences)Yuliang Zhao(European Foundation for Clinical Nanomedicine)Xin Zhou(Chinese Academy of Sciences)Wolfgang J. Parak(CIC biomaGUNE)

View via DOI Publisher page

Abstract

The design and use of materials in the nanoscale size range for addressing medical and health-related issues continues to receive increasing interest. Research in nanomedicine spans a multitude of areas, including drug delivery, vaccine development, antibacterial, diagnosis and imaging tools, wearable devices, implants, high-throughput screening platforms, etc. using biological, nonbiological, biomimetic, or hybrid materials. Many of these developments are starting to be translated into viable clinical products. Here, we provide an overview of recent developments in nanomedicine and highlight the current challenges and upcoming opportunities for the field and translation to the clinic.

Graphene and Nanomaterials Applications Nanoparticle-Based Drug Delivery Nanoplatforms for cancer theranosticsNanomedicineNanotechnologyDrug deliveryEngineeringSystems engineeringMaterials scienceNanoparticle

MeSH terms

AnimalsDrug CarriersHumansNeoplasmsParticle SizeDrug Delivery SystemsNanotechnologyNanomedicineNanoparticles

Funding

National Science Foundation
Alexander von Humboldt-Stiftung
European Commission
Deutscher Akademischer Austauschdienst
Deutsche Forschungsgemeinschaft
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
National Natural Science Foundation of China
Canadian Network for Research and Innovation in Machining Technology, Natural Sciences and Engineering Research Council of Canada
Generalitat de Catalunya
Fonds Wetenschappelijk Onderzoek
Innovation and Technology Commission
Universiteit Gent
Zhejiang University
Junta de Andalucía
Vlaamse regering
National Institutes of Health
Canadian Institutes of Health Research
Natural Sciences and Engineering Research Council of Canada
National Key Research and Development Program of China
National Cancer Institute
National Institute of Biomedical Imaging and Bioengineering
Division of Chemical, Bioengineering, Environmental, and Transport Systems
Division of Chemistry
Division of Emerging Frontiers